NEVVI Medicare utilization intelligence

← back

TEVAARWERK, AMYEM.D. NPI 1306879028 Clinician

Medical Oncology · ROCHESTER, MN

Specialty Medical Oncology — from billed Medicare claims
Trained WASHINGTON UNIVERSITY SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 24 years since medical school (class of 2002, self-reported to CMS)
Location ROCHESTER, MN · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 38 codes billed · 44,059 disclosed volume (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
2022–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2021-12
Data year CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed submitted charges across all codes were premium in CY2024. Included with Platform.

  • Charge, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
J9271 Injection, pembrolizumab, 1 mg premiumpremium premiumpremium
J1453 Injection, fosaprepitant, 1 mg premiumpremium premiumpremium
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj premiumpremium premiumpremium
J9267 Injection, paclitaxel, 1 mg premiumpremium premiumpremium
J9305 Injection, pemetrexed, not otherwise specified, 10 mg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
J9041 Injection, bortezomib, 0.1 mg premiumpremium premiumpremium
J2469 Injection, palonosetron hcl, 25 mcg premiumpremium premiumpremium
Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg premiumpremium premiumpremium
J2405 Injection, ondansetron hydrochloride, per 1 mg premiumpremium premiumpremium
J0461 Injection, atropine sulfate, 0.01 mg premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
J9045 Injection, carboplatin, 50 mg premiumpremium premiumpremium
J9190 Injection, fluorouracil, 500 mg premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
J9206 Injection, irinotecan, 20 mg premiumpremium premiumpremium
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg premiumpremium premiumpremium
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
96417 Administration of additional new drug or substance into vein, 1 hour or less premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less premiumpremium premiumpremium
J3490 Unclassified drugs premiumpremium premiumpremium
J9217 Leuprolide acetate (for depot suspension), 7.5 mg premiumpremium premiumpremium
J0640 Injection, leucovorin calcium, per 50 mg premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium

Showing the top 25 of 38 procedures this clinician billed. The full list is part of the premium platform. Notify me at launch →

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.